干细胞移植治疗肝硬化的研究进展  

Research progress in stem cell transplantation in the treatment of liver cirrhosis

作　　者：吴颖[1] 孙自勤[1] 江学良[1] 刘晓峰[1] 王要军[1] 

机构地区：[1]山东济南军区总医院消化内科,济南250031

出　　处：《新医学》2015年第6期346-349,共4页Journal of New Medicine

摘　　要：肝硬化是临床上常见的一种消化系统慢性疾病,是多种肝病患者疾病进展的终末阶段。失代偿期肝硬化患者会出现多种严重并发症,甚至危及生命。干细胞是组织中具有多潜能性、自我更新的细胞。近年来,随着干细胞技术的成熟和发展,干细胞移植治疗肝硬化患者取得了良好的疗效,具有广阔的发展前景。该文对干细胞移植治疗肝硬化的研究现状和进展进行阐述。Hepatic cirrhosis is a common chronic digestive disease in clinical practice,which is the end-stage progression of a variety of liver diseases.Patients with decompensated cirrhosis tend to present with multiple serious complications and may even die.Stem cells are pluripotent cells and have the potential of self-renewing.In recent years,along with the maturity and development of stem cell technique,favorable clinical efficacy has been achieved in the application of stem cell transplantation in treating liver cirrhosis and it has a promising prospect.In this paper,the current situation and research progress of stem cell transplantation in treating liver cirrhosis were elaborated.

关 键 词：肝硬化 干细胞 移植 

分 类 号：R575.2[医药卫生—消化系统]